Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Aytu Biopharma (AYTU) over the last 14 years, with Q4 2025 value amounting to $768000.0.

  • Aytu Biopharma's Accumulated Depreciation & Amortization rose 1797.24% to $768000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $768000.0, marking a year-over-year increase of 1797.24%. This contributed to the annual value of $714000.0 for FY2025, which is 6640.0% down from last year.
  • Per Aytu Biopharma's latest filing, its Accumulated Depreciation & Amortization stood at $768000.0 for Q4 2025, which was up 1797.24% from $735000.0 recorded in Q3 2025.
  • Aytu Biopharma's 5-year Accumulated Depreciation & Amortization high stood at $9.4 million for Q2 2022, and its period low was -$1.6 million during Q3 2021.
  • For the 5-year period, Aytu Biopharma's Accumulated Depreciation & Amortization averaged around $2.0 million, with its median value being $1.8 million (2022).
  • As far as peak fluctuations go, Aytu Biopharma's Accumulated Depreciation & Amortization plummeted by 686666.67% in 2021, and later soared by 245882.35% in 2022.
  • Quarter analysis of 5 years shows Aytu Biopharma's Accumulated Depreciation & Amortization stood at -$1.2 million in 2021, then surged by 351.56% to $3.1 million in 2022, then grew by 0.46% to $3.1 million in 2023, then plummeted by 78.85% to $651000.0 in 2024, then grew by 17.97% to $768000.0 in 2025.
  • Its last three reported values are $768000.0 in Q4 2025, $735000.0 for Q3 2025, and $714000.0 during Q2 2025.